ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 178,54
0,18%
Dow Jones
44 603,48
-0,24%
DAX
22 513,42
-0,43%
Brent Oil
74,645
-0,59%
Bitcoin
97 576,67
0,99%
Registration Strip Icon for discussion Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. TELA Bio Inc (TELA)

  7. TELA Bio Inc (TELA) Actualités

TELA

TELA Bio (TELA)

TELA Bio Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:TELA
DateHeureSourceTitreSymboleSociété
13/02/202518h07Edgar (US Regulatory)Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:TELATELA Bio Inc
12/02/202521h54Edgar (US Regulatory)Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain InvestorsNASDAQ:TELATELA Bio Inc
24/01/202522h05GlobeNewswire Inc.TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:TELATELA Bio Inc
19/11/202422h05GlobeNewswire Inc.TELA Bio to Participate in Piper Sandler’s 36th Annual Healthcare ConferenceNASDAQ:TELATELA Bio Inc
07/11/202422h15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TELATELA Bio Inc
07/11/202422h05GlobeNewswire Inc.TELA Bio Reports Third Quarter 2024 Financial ResultsNASDAQ:TELATELA Bio Inc
28/10/202421h06Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:TELATELA Bio Inc
24/10/202422h26Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TELATELA Bio Inc
24/10/202422h05GlobeNewswire Inc.TELA Bio Announces Closing of Public Offering of Common Stock and Pre-Funded Warrants and Full Exercise of the Underwriters’ Option to Purchase Additional SharesNASDAQ:TELATELA Bio Inc
23/10/202423h15Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:TELATELA Bio Inc
23/10/202414h07GlobeNewswire Inc.TELA Bio Announces Pricing of Public Offering of Common Stock and Pre-Funded WarrantsNASDAQ:TELATELA Bio Inc
22/10/202422h05GlobeNewswire Inc.TELA Bio Announces Proposed Public Offering of Common Stock and Pre-Funded WarrantsNASDAQ:TELATELA Bio Inc
17/10/202422h05GlobeNewswire Inc.TELA Bio to Announce Third Quarter 2024 Financial ResultsNASDAQ:TELATELA Bio Inc
13/08/202422h20Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:TELATELA Bio Inc
12/08/202422h05GlobeNewswire Inc.TELA Bio Reports Second Quarter 2024 Financial Results and Reiterates Full Year 2024 Revenue GuidanceNASDAQ:TELATELA Bio Inc
25/07/202422h05GlobeNewswire Inc.TELA Bio to Participate in the Canaccord Genuity 44th Annual Growth ConferenceNASDAQ:TELATELA Bio Inc
22/07/202422h05GlobeNewswire Inc.TELA Bio to Announce Second Quarter 2024 Financial ResultsNASDAQ:TELATELA Bio Inc
10/06/202415h00Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:TELATELA Bio Inc
06/06/202422h55Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:TELATELA Bio Inc
04/06/202422h05GlobeNewswire Inc.TELA Bio Appoints Jeffrey Blizard to its Board of DirectorsNASDAQ:TELATELA Bio Inc
20/05/202422h03GlobeNewswire Inc.TELA Bio Appoints Greg Firestone as Chief Commercial OfficerNASDAQ:TELATELA Bio Inc
09/05/202422h05GlobeNewswire Inc.TELA Bio Reports First Quarter 2024 Financial ResultsNASDAQ:TELATELA Bio Inc
25/04/202413h00GlobeNewswire Inc.TELA Bio to Announce First Quarter 2024 Financial ResultsNASDAQ:TELATELA Bio Inc
15/04/202413h00GlobeNewswire Inc.TELA Bio Announces U.S. Commercial Launch of Robotic-Compatible OviTex® IHR – Addressing the Need for a More Natural Repair in Inguinal Hernia ProceduresNASDAQ:TELATELA Bio Inc
08/04/202413h00GlobeNewswire Inc.TELA Bio Welcomes Acclaimed Surgeon as Vice President of Medical Affairs and Surgeon StrategyNASDAQ:TELATELA Bio Inc
21/03/202421h05GlobeNewswire Inc.TELA Bio Achieves Record Fourth Quarter and Full Year 2023 Revenues and Reports Complete Financial ResultsNASDAQ:TELATELA Bio Inc
21/03/202412h00GlobeNewswire Inc.TELA Bio Announces U.S. Commercial Launch of LIQUIFIX™ – the Only FDA-Approved Liquid Adhesive for Internal Use in Hernia SurgeryNASDAQ:TELATELA Bio Inc
20/03/202412h00GlobeNewswire Inc.MIMEDX Expands Portfolio with Fibrillar Collagen Wound DressingNASDAQ:TELATELA Bio Inc
20/03/202412h00GlobeNewswire Inc.TELA Bio Announces Sale of Distribution Rights for Wound Care Product to MIMEDXNASDAQ:TELATELA Bio Inc
29/02/202413h00GlobeNewswire Inc.TELA Bio to Announce Fourth Quarter and Full Year 2023 Financial ResultsNASDAQ:TELATELA Bio Inc
 Showing the most relevant articles for your search:NASDAQ:TELA

Dernières Valeurs Consultées

SPI
SP500
S&P 500
EU
RNO
Renault
COIN
DOGEUSD
Dogecoin
NYSE
NKE
Nike
EU
LR
Legrand
NASDAQ
GOOGL
Alphabet
EU
PX4
SBF 120
EU
ACA
Credit Agricole
NYSE
JPM
JP Morgan Chase
COIN
BTCUSD
Bitcoin
EU
ML
Michelin
EU
PX1
CAC 40
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2025 ADVFN PLC - Tous droits réservés

Supprimer les publicités

Inscrivez-vous pour une expérience sans publicité

Aucune publicité

Essayez maintenant

Conserver les annonces